CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on combating antimicrobial resistance by designing new antibiotics that specifically target bacterial infections, particularly urinary tract infections. It utilizes bioorganic synthesis to create glycan mimics that can bind to bacterial lectins, aiming to enhance drug delivery and efficacy.
Antimicrobial resistance (AMR) represents a significant health and economic challenge worldwide.
Due to the fact that bacterial infections affect most people at some point in their lives, methods for specific recognition and targeting of bacteria are of key importance in developing approaches to counter the growth of AMR, where the discovery of novel antibiotics represents a global challenge in urinary tract infections (UTI).
Progress in bioorganic synthesis has provided access to knowledge of t…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
